$1.05
0.00%There's no data available for key stats
There's no data available for ratios/profitability stats
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Halozyme Therapeutics (HALO) Surges 5.6%: Is This an Indication of Further Gains?
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
Seres Therapeutics: Evaluating Vowst's Market Challenges (Rating Downgrade)